Ozempic, Wegovy and Mounjaro face US lawsuits over rare vision-loss risk
Global - Africa
Archived
•
September 23, 2026
•
Dozens of people in the United States have sued the manufacturers of popular GLP-1 drugs, claiming that the medicines caused a rare eye condition that can result in permanent vision loss, according to US media reports.
Source: Africanews | https://www.africanews.com/feed/rss - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



